← Open Payments lookup

CHRISTOPHER KAMPFE: Open Payments

NPI 1154333045 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,181 in 99 payments from 26 companies in 2025. Trend: 2023 $2,159 · 2024 $1,647 · 2025 $2,181

Food & beverage: $2,181
CompanyPaymentsAmount
ABBVIE INC.14$403
Lilly USA, LLC12$162
Axsome Therapeutics, Inc.6$160
Boston Scientific Corporation1$142
Boehringer Ingelheim Pharmaceuticals, Inc.18$141
Gilead Sciences, Inc.2$125
Novo Nordisk Inc5$110
Arthrex, Inc.1$106
Sumitomo Pharma America, Inc.6$106
ABIOMED1$101

Products named: VRAYLAR, JARDIANCE, General - Therapies, Symbravo, GEMTESA, Yeztugo, MOUNJARO, REXULTI.

Industry payments across CA — which companies pay providers there.